The startup operates a digital health platform that utilizes machine learning and artificial intelligence to analyze optical data from existing smart devices for disease detection. This technology enables users to gain actionable health insights through their smartphones, addressing the need for accessible and non-invasive health monitoring solutions.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional healthcare models rely heavily on infrequent and localized data collection, often missing early signs of developing diseases. Existing health monitoring tools are typically expensive, centralized, and require specialized equipment, limiting accessibility and scalability. This results in delayed detection and intervention, leading to increased healthcare costs and poorer patient outcomes.
Solution
BioTrillion offers a HealthAI platform, BioEngine4D™, that leverages smartphone technology and AI-powered computer vision to detect diseases from a simple selfie. The platform analyzes subtle features in the eyes and face, extracting key health vitals and disease biomarkers. This approach enables frequent, convenient, and scalable health monitoring, shifting from reactive treatment to proactive prevention. By transforming smartphones into health monitoring devices, BioTrillion aims to provide individuals and healthcare providers with earlier disease detection capabilities and improved risk prediction. The software-only technology can be integrated into existing mobile apps via API/SDK, allowing partners to incorporate it into their business models and user journeys.
Target Audience
BioTrillion's primary customers include pharmaceutical companies, life and health insurance providers, telehealth platforms, healthcare providers, and individual consumers seeking proactive health management tools.
Features
- AI-powered analysis of facial features from smartphone videos to extract digital biomarkers
- DiseaseSignatures™ analytics to combinatorially detect and monitor a wide range of diseases
- HealthySelfie™ smartphone app for users to capture and analyze their health data
- API/SDK integration for enterprise partners to incorporate BioEngine4D™ into existing mobile apps
- Decentralized clinical trial capabilities through remote and continuous monitoring of physiologic endpoints
- Risk assessment for life insurance through objective insights into an individual’s health and longevity
- Telehealth 2.0 insights by integrating AI-powered vital sign measurement into telehealth services
- Consumer health empowerment through multi-disease risk detection via smartphone